Alkylating Polycyclic Aromatic Compounds to Reduce Mutagenicity
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Heavy Vacuum Gas Oils (HVGOs) contain carcinogenic polycyclic aromatic compounds (PACs) with bay regions, which are mutagenic and pose safety risks in industrial applications like rubber processing and inks, leading to the need for safer alternatives with low mutagenicity and good physical and chemical properties.
Innovation Solution
Alkylating polycyclic aromatic compounds with styrene or hexene in the presence of catalysts like AlCl3 or sulfuric acid to reduce mutagenicity, resulting in alkylated compounds with low mutagenicity and retained aromaticity, suitable for use as rubber processing oils and inks.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Object-affected harmful factors
If hydrotreating is used to remove carcinogenic PACs, then mutagenicity is reduced to safe levels, but solvency and aromaticity are significantly lost
Solution Approach 1:
The patent extracts and removes only the carcinogenic polycyclic aromatic compounds (PACs) with bay regions from the heavy vacuum gas oil through solvent extraction, while preserving the beneficial aromatic compounds that provide solvency. This selective extraction approach removes the harmful fraction without sacrificing the functional aromatic content needed for rubber processing oil performance.
Solution Approach 2:
The patent applies local quality by treating different components of the oil differently: carcinogenic PACs are removed while beneficial aromatics are retained. The final product has non-uniform composition with specific removal of harmful bay-region compounds while maintaining overall aromaticity and solvency properties needed for industrial applications.
2Object-affected harmful factors
If solvent extraction is used to remove PACs, then carcinogenicity is reduced, but yield is lost and solvent recovery costs increase
Solution Approach 1:
The patent converts the harmful carcinogenic PACs into a separable fraction that can be removed, while the remaining oil gains the benefit of reduced carcinogenicity while maintaining yield. The solvent extraction process transforms a harmful component into a removable fraction, leaving a safer product with preserved yield and performance characteristics.
3Object-affected harmful factors
If hydrotreating above 800 psi is used to saturate aromatic rings, then carcinogenicity is eliminated, but aromaticity drops to 10-25% and performance decreases
Solution Approach 1:
Instead of saturating all aromatic rings through hydrotreating, the patent selectively extracts only the carcinogenic PACs with bay regions. This preserves the aromatic rings that provide solvency and performance while removing only the harmful fraction, maintaining aromaticity at levels sufficient for industrial applications.
Solution Approach 2:
The patent changes the approach from chemical modification (saturating rings via hydrotreating) to physical separation (solvent extraction). This parameter change allows removal of carcinogenic compounds while preserving aromatic character, achieving carcinogenicity reduction without sacrificing aromaticity or performance.
4Object-affected harmful factors
If DMSO extraction is used to produce TDAE, then carcinogenicity is reduced, but yield loss of 15% occurs and solvent recovery becomes costly
Solution Approach 1:
The patent employs a solvent extraction system that can be designed for efficient solvent recovery and reuse, reducing both yield loss and recovery costs compared to DMSO extraction. The process uses solvents that are easier to recover and recycle, minimizing material loss and operational costs while achieving carcinogenicity reduction.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The process effectively reduces mutagenicity of PACs to safe levels, maintaining high solvency and physical properties, making the resulting oils suitable for industrial use without the hazards associated with carcinogenic compounds.
Implementation Method 1
contacting the polycyclic aromatic compounds with alkylating agent selected from styrene and hexene in the presence of a catalyst selected from Lewis acids or protonic acids such as AlCl3, sulfuric acid, and methyl sulfonic acid to alkylate the polycyclic aromatic compounds
Implementation Method 2
in the presence of a catalyst selected from Lewis acids or protonic acids such as AlCl3, sulfuric acid, and methyl sulfonic acid
Data Source
AI summary
A method for reducing the mutagenicity of polycyclic aromatic compounds (PAC's) having one or more bay regions which involves alkylating the PAC's with an alkylating agent in the presence of a catalyst to lower the mutagenicity down to as much as about 0.1. The resulting alkylated polycyclic aromatic compounds retain their physical and chemical properties for safe industrial use including as rubber processing oils, inks, etc.